433 related articles for article (PubMed ID: 12624111)
21. Curcumin is an inhibitor of p300 histone acetylatransferase.
Marcu MG; Jung YJ; Lee S; Chung EJ; Lee MJ; Trepel J; Neckers L
Med Chem; 2006 Mar; 2(2):169-74. PubMed ID: 16787365
[TBL] [Abstract][Full Text] [Related]
22. The histone acetyltransferase activity of PCAF cooperates with the brahma/SWI2-related protein BRG-1 in the activation of the enhancer A of the MHC class I promoter.
Brockmann D; Lehmkühler O; Schmücker U; Esche H
Gene; 2001 Oct; 277(1-2):111-20. PubMed ID: 11602348
[TBL] [Abstract][Full Text] [Related]
23. Steroid receptor coactivator-1 is a histone acetyltransferase.
Spencer TE; Jenster G; Burcin MM; Allis CD; Zhou J; Mizzen CA; McKenna NJ; Onate SA; Tsai SY; Tsai MJ; O'Malley BW
Nature; 1997 Sep; 389(6647):194-8. PubMed ID: 9296499
[TBL] [Abstract][Full Text] [Related]
24. Direct association of p300 with unmodified H3 and H4 N termini modulates p300-dependent acetylation and transcription of nucleosomal templates.
An W; Roeder RG
J Biol Chem; 2003 Jan; 278(3):1504-10. PubMed ID: 12421817
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes.
Bandyopadhyay D; Okan NA; Bales E; Nascimento L; Cole PA; Medrano EE
Cancer Res; 2002 Nov; 62(21):6231-9. PubMed ID: 12414652
[TBL] [Abstract][Full Text] [Related]
26. Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones.
Deng L; de la Fuente C; Fu P; Wang L; Donnelly R; Wade JD; Lambert P; Li H; Lee CG; Kashanchi F
Virology; 2000 Nov; 277(2):278-95. PubMed ID: 11080476
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of benzamide derivatives of anacardic acid and their cytotoxic activity.
Chandregowda V; Kush A; Reddy GC
Eur J Med Chem; 2009 Jun; 44(6):2711-9. PubMed ID: 19246131
[TBL] [Abstract][Full Text] [Related]
28. A Small Molecule Activator of p300/CBP Histone Acetyltransferase Promotes Survival and Neurite Growth in a Cellular Model of Parkinson's Disease.
Hegarty SV; O'Leary E; Solger F; Stanicka J; Sullivan AM; O'Keeffe GW
Neurotox Res; 2016 Oct; 30(3):510-20. PubMed ID: 27256286
[TBL] [Abstract][Full Text] [Related]
29. Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation.
Stiehl DP; Fath DM; Liang D; Jiang Y; Sang N
Cancer Res; 2007 Mar; 67(5):2256-2264. PubMed ID: 17332356
[TBL] [Abstract][Full Text] [Related]
30. Application of a fluorescent histone acetyltransferase assay to probe the substrate specificity of the human p300/CBP-associated factor.
Trievel RC; Li FY; Marmorstein R
Anal Biochem; 2000 Dec; 287(2):319-28. PubMed ID: 11112280
[TBL] [Abstract][Full Text] [Related]
31. Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein.
Seo SB; McNamara P; Heo S; Turner A; Lane WS; Chakravarti D
Cell; 2001 Jan; 104(1):119-30. PubMed ID: 11163245
[TBL] [Abstract][Full Text] [Related]
32. Multiple roles for acetylation in the interaction of p300 HAT with ATF-2.
Karanam B; Wang L; Wang D; Liu X; Marmorstein R; Cotter R; Cole PA
Biochemistry; 2007 Jul; 46(28):8207-16. PubMed ID: 17590016
[TBL] [Abstract][Full Text] [Related]
33. The transcriptional coactivators p300 and CBP are histone acetyltransferases.
Ogryzko VV; Schiltz RL; Russanova V; Howard BH; Nakatani Y
Cell; 1996 Nov; 87(5):953-9. PubMed ID: 8945521
[TBL] [Abstract][Full Text] [Related]
34. New anacardic acid-inspired benzamides: histone lysine acetyltransferase activators.
Souto JA; Benedetti R; Otto K; Miceli M; Alvarez R; Altucci L; de Lera AR
ChemMedChem; 2010 Sep; 5(9):1530-40. PubMed ID: 20683922
[TBL] [Abstract][Full Text] [Related]
35. Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein.
Guidez F; Howell L; Isalan M; Cebrat M; Alani RM; Ivins S; Hormaeche I; McConnell MJ; Pierce S; Cole PA; Licht J; Zelent A
Mol Cell Biol; 2005 Jul; 25(13):5552-66. PubMed ID: 15964811
[TBL] [Abstract][Full Text] [Related]
36. Exploring the binding affinities of p300 enzyme activators CTPB and CTB using docking method.
Devipriya B; Parameswari AR; Rajalakshmi G; Palvannan T; Kumaradhas P
Indian J Biochem Biophys; 2010 Dec; 47(6):364-9. PubMed ID: 21355420
[TBL] [Abstract][Full Text] [Related]
37. Assays for Validating Histone Acetyltransferase Inhibitors.
Waddell AR; Liao D
J Vis Exp; 2020 Aug; (162):. PubMed ID: 32831305
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators.
Lee KC; Li J; Cole PA; Wong J; Kraus WL
Mol Endocrinol; 2003 May; 17(5):908-22. PubMed ID: 12586842
[TBL] [Abstract][Full Text] [Related]
39. Regulation of the homeodomain CCAAT displacement/cut protein function by histone acetyltransferases p300/CREB-binding protein (CBP)-associated factor and CBP.
Li S; Aufiero B; Schiltz RL; Walsh MJ
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7166-71. PubMed ID: 10852958
[TBL] [Abstract][Full Text] [Related]
40. Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative.
Ghizzoni M; Boltjes A; Graaf Cd; Haisma HJ; Dekker FJ
Bioorg Med Chem; 2010 Aug; 18(16):5826-34. PubMed ID: 20655754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
